4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.
Open accessThe DOI matches its Crossref record.
Abstract
Estradiol is converted to catechol estrogens via 2- and 4-hydroxylation by cytochrome P450 enzymes. 4-Hydroxyestradiol elicits biological activities distinct from estradiol, most notably an oxidant stress response induced by free radicals generated by metabolic redox cycling reactions. In this study, we have examined 2- and 4-hydroxylation of estradiol by microsomes of human uterine myometrium and of associated myomata. In all eight cases studied, estradiol 4-hydroxylation by myoma has been substantially elevated relative to surrounding myometrial tissue (minimum, 2-fold; mean, 5-fold). Estradiol 2-hydroxylation in myomata occurs at much lower rates than 4-hydroxylation (ratio of 4-hydroxyestradiol/2-hydroxyestradiol, 7.9 +/- 1.4) and does not significantly differ from rates in surrounding myometrial tissue. Rates of myometrial 2-hydroxylation of estradiol were also not significantly different from values in patients without myomata. We have used various inhibitors to establish that 4-hydroxylation is catalyzed by a completely different cytochrome P450 than 2-hydroxylation. In myoma, alpha-naphthoflavone and a set of ethynyl polycyclic hydrocarbon inhibitors (5 microM) each inhibited 4-hydroxylation more efficiently (up to 90%) than 2-hydroxylation (up to 40%), indicating > 10-fold differences in Ki (<0.5 microM vs. > 5 microM). These activities were clearly distinguished from the selective 2-hydroxylation of estradiol in placenta by aromatase reported previously (low Km, inhibition by Fadrozole hydrochloride or ICI D1033). 4-Hydroxylation was also selectively inhibited relative to 2-hydroxylation by antibodies raised against cytochrome P450 IB1 (rat) (53 vs. 17%). These data indicate that specific 4-hydroxylation of estradiol in human uterine tissues is catalyzed by a form(s) of cytochrome P450 related to P450 IB1, which contribute(s) little to 2-hydroxylation. This enzyme(s) is therefore a marker for uterine myomata and may play a role in the etiology of the tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
“4-Hydroxylation of estrogens is not extensive in the liver, but this reaction is much more common in the extrahepatic target tissues of estrogens, such as pituitary (Bui and Weisz, 1988), myometrium and myomal tissues (Lier et al., 1995), and breast (Lier et al.”
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Self-citationSummary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer
Moorthy, B., Chu, C., & Carlin, D. J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv040 · Cited by 801
Guengerich, F. P. (1995) · Cytochrome P450 · doi:10.1007/978-1-4757-2391-5_14 · Cited by 728
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
Shimada, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.257 · Cited by 606
Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations
Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., & Roy, D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024247 · Cited by 595
Self-citationEtiology and pathogenesis of uterine leiomyomas: a review.
Flake, G. P., Andersen, J., & Dixon, D. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5787 · Cited by 583
Is Estradiol a Genotoxic Mutagenic Carcinogen?1
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0386 · Cited by 484
Self-citationLee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 456
Self-citation4-Hydroxylation of estrogens as marker of human mammary tumors.
Liehr, J. G., & Ricci, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3294 · Cited by 414
Self-citationChapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation
Yager, J. D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024245 · Cited by 398
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 341
Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1
Murray, G. I., Melvin, W. T., Greenlee, W. F., & Burke, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.297 · Cited by 336
Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
Spink, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.291 · Cited by 308
Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1
Doostdar, H., Burke, M. D., & Mayer, R. T. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00215-2 · Cited by 284
Role of Cytochrome P450 Enzymes in Drug-Drug Interactions
Guengerich, F. P. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60200-8 · Cited by 284
Contributions of Human Enzymes in Carcinogen Metabolism
Rendic, S., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300132k · Cited by 279
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
Jefcoate, C. R., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., Tekmal, R., Demers, L., Pauley, R., et al. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024248 · Cited by 260
Self-citationActivation of procarcinogens by human cytochrome P450 enzymes
Peter Guengerich, F., & Shimada, T. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00037-2 · Cited by 260
Inflammation and Endometrial Cancer: A Hypothesis
Modugno, F., Ness, R. B., Chen, C., & Weiss, N. S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0493 · Cited by 254
Hakkola, J., Pelkonen, O., Pasanen, M., & Raunio, H. (1998) · Critical Reviews in Toxicology · doi:10.1080/10408449891344173 · Cited by 229
Avoidable Causes of Breast Cancer: The Known, Unknown, and the Suspected
DAVIS, D. L., AXELROD, D., OSBORNE, M., TELANG, N., BRADLOW, H. L., & SITTNER, E. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48597.x · Cited by 16
Metadata
- Authors
- Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan, E. V., Hokanson, J. A., & Zhu, B. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-09-26
- Volume
- 92
- Issue
- 20
- Pages
- 9220-9224
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2005648074
- Cited by
- 208
- References
- 0
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.